Novo Nordisk A S (NVO) Common Equity (2015)
Novo Nordisk A S (NVO) posted Common Equity of $45.27 billion for Q4 2016, down 3.6% from $46.97 billion a year earlier.
Powered by 
Analysis
Novo Nordisk A S (NVO) Common Equity (2015) Analysis & Trends
Since Q4 2013, Novo Nordisk A S has reported Common Equity for 4 quarters.
- Annual Common Equity shows a three-year compound annual growth rate of 2.1% (FY2013 to FY2016).
- In prior years, Novo Nordisk A S's Common Equity was $46.97 billion in FY2015 (+16.6%), $40.29 billion in FY2014 (-5.3%) and $42.57 billion in FY2013.
- The Q4 2016 figure stands as the lowest quarterly Common Equity since Q4 2014.
Peer Set
Peer Comparison
API Access
Novo Nordisk A S Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NVO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NVO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NVO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();